ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Nov 2, 2011
Clorox Posts Fiscal First-Quarter Results; Reaffirms 2012 Outlook
Clorox posted less-than-impressive fiscal first-quarter results, as higher commodity costs took their toll. Management expects gross margins will remain flat through fiscal 2012, but we disagree. We remain on the sidelines, despite the firm's solid cash-flow generation.
Nov 2, 2011
Pfizer Reports Decent Third-Quarter Results; Loss of Exclusivity on Blockbuster Drug Lipitor Concerning
All things considered, we're less than thrilled with Pfizer. The firm will be losing exclusivity on its $10-billion-per-year blockbuster drug Lipitor at the end of November, and its earnings-per-share expansion is largely driven by buybacks. Though its valuation is compelling, there are better opportunities out there.
Oct 31, 2011
Republic Services Puts Up Nice Third Quarter; Best Organic Revenue Growth Since 2008
Rubbish-handler Republic Services posted nice third-quarter results and its best organic revenue growth since 2008. It remains one of our best ideas and dividend picks.
Oct 31, 2011
Precision Castparts Reports Strong Fiscal Second Quarter; Aerospace Growth Remains Impressive
Metal-bender Precision Castparts reported solid fiscal second-quarter results. Boeing's 787 Dreamliner to be key driver going forward.
Oct 26, 2011
3M Posts Another Weak Quarter; Results Should Not Be Extrapolated to Broader Economy
3M put up weak third-quarter results, but sales growth (excluding its LCD end market) remains solid. We're not ready to pull the trigger on the firm's shares, and we do not think investors can extrapolate 3M's report to the broader economy.
Oct 25, 2011
Amgen Posts Mixed Third-Quarter Results, Sales of Epogene Nosedive
Amgen's third-quarter results were mixed, as revenue and earnings growth was overshadowed by a legal charge and weakness with Epogene. We think the company looks cheap, but are waiting cautiously for improvement in its score on our Valuentum Buying Index.
Oct 24, 2011
Honeywell Lifts 2011 Outlook; Organic Growth Remains Robust
Honeywell's third-quarter results showed no signs of slowing demand. The conglomerate raised its 2011 earnings outlook and noted that it expects positive organic expansion in 2012.
Oct 22, 2011
McDonald's Third Quarter Was Solid
We walk through the seller of Big-Mac's strong third-quater performance. Though we think the firm is fairly valued, we're big fans of its dividend yield.
Oct 21, 2011
Microsoft Reports Fiscal First Quarter; Slows Bleeding at Bing; Office and "Cloud" Remain Strong
Microsoft posted an in-line fiscal first quarter. We're growing more interested in the firm after its dividend hike.
Oct 21, 2011
Lilly's Third-Quarter Results Were Mixed; Patent Cliff Represents Major Risk
Lilly reported mixed third-quarter results, which revealed an earnings decline. The loss of US patent exclusivity on its top two drugs in the next couple years will be difficult to overcome. Investors may see a higher dividend yield on the stock, but only because of price declines.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.